Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, announces the appointment of Dr Bruno Besse as the Company’s Chief Medical Officer.
Dr Besse will be in charge of all patient-related clinical development, interactions with regulators, and pharmacovigilance activities. He will also supervise patient stratification and the positioning of Quantum Genomics’ drug candidates.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2017/04/QUANTUM_PR_B.Besse-Nomination_20170425_EN.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]